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Alternative splice isoforms are common and important
and have been shown to impact many human diseases.
A new study by Nellore et al. offers a comprehensive
study of splice junctions in humans by re-analyzing over
21,500 public human RNA sequencing datasets.analyze the transcriptome, the complete set of tran-
scripts expressed in a given cell. This approach isIntroduction
A newly published study by Nellore et al. in Genome
Biology provides us with the most comprehensive view
of human transcriptome splicing to date, having (re)ana-
lyzed over 21,500 RNA sequencing (RNA-seq) datasets
and discovered 56,865 novel splice junctions [1].
RNA splicing is a post-transcriptional RNA process-
ing mechanism occurring in eukaryotic organisms
whereby introns are removed from pre-mRNA leading
to mature mRNA molecules, or transcripts, consisting
of joined exons. The process of RNA splicing gener-
ates distinct transcript variants of the same gene,
referred to as alternative transcript isoforms, the
translation of which leads to distinct protein products.
Thus, alternative splicing is a critical process that en-
sures protein diversity, with most of the multi-exon
genes in humans generating multiple alternative tran-
script isoforms.Alternative splicing affects human disease
Dysregulation of alternative splicing can have major
functional consequences through the expression of ab-
normal isoforms that contribute to disease progression.
Isoform switching, where the most abundant transcript
isoform has changed between two conditions (e.g., can-
cer and normal cells) is a common mechanism. Recently,
Sebestyén et al. [2] reported recurrent isoform switches
for known tumor-driver genes (e.g., PPARG, MITF, and
MYH11) across seven cancer types that resulted in
altered gene function; and (amongst many others)* Correspondence: christelle.robert@roslin.ed.ac.uk
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muscular dystrophy [3] and cystic fibrosis [4].RNA-seq as an incredibly powerful method for
splice junction discovery
RNA-seq has now become the standard method to
commonly used to identify the diverse set of tran-
script types (e.g., mRNA, noncoding RNAs) and their
isoform structure (splicing patterns); to quantify
transcript-level expression and the changes in expres-
sion under various experimental conditions; and to
discover novel transcript isoforms or splice junctions;
though care must be taken as accurate alignment and
quantification is difficult due to the high similarity
between some transcripts and genes [5].
Remarkably, Nellore et al. have re-analyzed over
21,500 public RNA-seq datasets, producing the most
comprehensive catalogue of splice junctions to date, as
well as tracking the annotation of human RNA splicing
over time [1].Most common junctions are annotated but many
rare junctions are not
Nellore et al. find that most of the reads that map to
splice junctions map to junctions that are already
known; specifically, in 10,090 of 10,311 datasets that
met the authors’ filtering criteria, over 95% of junc-
tion reads overlap junctions found in the existing an-
notation. However, although most splice junctions
with high read coverage have been documented, there
remains a large number of splice junctions that occur
across multiple samples that have not. For example,
in 3389 samples from the same set (n = 10,311), fewer
than 80% of the observed junctions are annotated. In
total, Nellore et al. report 56,865 novel junctions
(18.6%) found in at least 1000 samples. Thus, com-
parison of multiple independent studies can reveal
many unannotated junctions.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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Nellore et al. confirm that variation in unannotated junc-
tion expression across samples strongly correlates with
both junction sequencing depth and read length. High
read coverage across splice junctions provides stronger
evidence that it is real and expressed; and an increased
read length allows for a larger proportion of reads to be
mapped across splice junctions. Thus, both parameters,
read depth and read length, strongly influence junction
discovery power.Most junctions have now been discovered…in
human
From 2009 to 2013, splice junction discovery has
increased over time with spikes of discovery mostly due to
large-scale sequencing projects such as the Human Refer-
ence Epigenome Mapping Project [6] (with over 200,000
newly discovered junctions), followed by ENCODE [7]
and the Illumina Body Map 2.0 projects. By 2013, the
splice junction discovery process reached a plateau, at
which point 96.1% of annotated junctions were already
discovered. For example, the large-scale GEUVADIS [8]
project contributed relatively few novel well-supported
splice junctions from lymphoblastoid cell lines, as those
cell lines had been well-studied by that time.What this means for studies in other species
Accurate gene-level and transcript-level expression analyses
often rely on the completeness of transcript and splice
junction annotation, and research suffers if that annotation
is incomplete. Unfortunately, such information is not at the
same level of completion for species other than human—-
beyond human and mouse, other animal genomes can lack
up to 20 megabases of annotation [9]—and even for species
as well-studied as human, it is now clear that the transcript
annotations are not fully complete.
The effort of Nellore et al. provides an unprecedented
insight into the splice junction usage in humans through
large-scale RNA-seq data analysis and further highlights the
need for similar studies in other less well-characterized spe-
cies [10]. The data and resource provided by Nellore et al.
will be of importance to anyone studying RNA in humans
and will specifically impact on our ability to study splice
variation effects in human disease.
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